Phibro Animal Health

Phibro Animal Health SA engages in the manufacture and marketing of a range of animal health and nutrition products, primarily medicated feed additives, in Belgium. The company’s plant utilizes fermentation processes to produce the ingredients semduramicin-crystalline and virginiamycin; and also manufactures Stafac formulations. It primarily sells medicated feed additives to the poultry, swine, and cattle markets. The company, formerly known as Phibro Animal Health (Belgium) SPRL, is based in Rixensart, Belgium. Phibro Animal Health SA was acquired by Glaxosmithkline Biologicals SA.